Financials Genetec Corporation

Equities

4492

JP3428000008

IT Services & Consulting

Market Closed - Japan Exchange 11:30:00 05/07/2024 am IST 5-day change 1st Jan Change
719 JPY +0.56% Intraday chart for Genetec Corporation +3.60% +31.68%

Valuation

Fiscal Period: March 2020 2021 2022 2023 2024
Capitalization 1 1,997 3,470 3,269 3,450 11,345
Enterprise Value (EV) 1 1,039 2,064 2,275 3,350 10,817
P/E ratio 9.92 x 20.4 x 58.9 x 150 x 27.8 x
Yield 0.26% 1.06% 1.14% 1.09% -
Capitalization / Revenue 0.42 x 0.85 x 0.7 x 0.59 x 1.59 x
EV / Revenue 0.22 x 0.51 x 0.49 x 0.57 x 1.51 x
EV / EBITDA 29,19,882 x 73,99,038 x 1,00,24,211 x 1,29,35,600 x 1,39,74,834 x
EV / FCF 2,17,69,173 x 55,67,988 x -1,64,14,759 x -1,01,33,294 x 2,26,40,548 x
FCF Yield 0% 0% -0% -0% 0%
Price to Book 1.48 x 1.9 x 1.76 x 1.86 x 5.13 x
Nbr of stocks (in thousands) 8,964 11,076 11,223 11,313 11,390
Reference price 2 222.8 313.3 291.3 305.0 996.0
Announcement Date 26/06/20 25/06/21 29/06/22 28/06/23 26/06/24
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2019 2020 2021 2022 2023 2024
Net sales 1 4,482 4,720 4,079 4,683 5,864 7,147
EBITDA - 356 279 227 259 774
EBIT 1 260 336 254 191 106 629
Operating Margin 5.8% 7.12% 6.23% 4.08% 1.81% 8.8%
Earnings before Tax (EBT) 1 275 326 275 116 87 628
Net income 1 179 212 173 56 23 414
Net margin 3.99% 4.49% 4.24% 1.2% 0.39% 5.79%
EPS 2 19.97 22.45 15.33 4.950 2.033 35.80
Free Cash Flow - 47.75 370.8 -138.6 -330.6 477.8
FCF margin - 1.01% 9.09% -2.96% -5.64% 6.68%
FCF Conversion (EBITDA) - 13.41% 132.89% - - 61.72%
FCF Conversion (Net income) - 22.52% 214.31% - - 115.4%
Dividend per Share 2 0.5833 0.5833 3.333 3.333 3.333 -
Announcement Date 13/02/20 26/06/20 25/06/21 29/06/22 28/06/23 26/06/24
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2021 S1 2022 S1 2022 Q3 2023 Q1 2023 S1 2023 Q3 2024 Q1 2024 S1 2024 Q3
Net sales 1 1,954 2,159 1,091 1,203 2,537 1,360 1,439 3,159 1,774
EBITDA - - - - - - - - -
EBIT 1 36 165 39 -175 -150 -48 -17 196 105
Operating Margin 1.84% 7.64% 3.57% -14.55% -5.91% -3.53% -1.18% 6.2% 5.92%
Earnings before Tax (EBT) 1 36 158 -4 -182 -177 -51 -20 197 112
Net income 1 23 86 -7 -131 -131 -50 -19 119 79
Net margin 1.18% 3.98% -0.64% -10.89% -5.16% -3.68% -1.32% 3.77% 4.45%
EPS 2 2.140 3.873 -0.6400 -11.68 -11.62 -4.480 -1.757 10.53 6.880
Dividend per Share - 0.6667 - - - - - 3.333 -
Announcement Date 05/11/20 15/11/21 14/02/22 10/08/22 14/11/22 14/02/23 10/08/23 14/11/23 14/02/24
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024
Net Debt 1 - - - - - -
Net Cash position 1 432 958 1,406 994 100 528
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - 47.8 371 -139 -331 478
ROE (net income / shareholders' equity) 20.9% 16.4% 9.99% 3.04% 1.24% 20.3%
ROA (Net income/ Total Assets) 7.38% 8.56% 5.74% 3.92% 1.8% 9.1%
Assets 1 2,426 2,477 3,016 1,430 1,280 4,550
Book Value Per Share 2 105.0 151.0 165.0 165.0 164.0 194.0
Cash Flow per Share 2 75.30 104.0 134.0 92.80 94.70 102.0
Capex - 6 19 93 100 23
Capex / Sales - 0.13% 0.47% 1.99% 1.71% 0.32%
Announcement Date 13/02/20 26/06/20 25/06/21 29/06/22 28/06/23 26/06/24
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
  1. Stock Market
  2. Equities
  3. 4492 Stock
  4. Financials Genetec Corporation